Effect of low-dose rivaroxaban on bleeding events in low-weight patients with nonvalvular atrial fibrillation: a retrospective propensity score-matched cohort study
In the real world, in lower-weight patients with nonvalvular atrial fibrillation, a reduced dose of rivaroxaban did not reduce the risk of bleeding, and this was consistent in patients weighing less than 50 kg.
Authors
- Zhenhuan Chen (ORCID: https://orcid.org/0000-0001-5819-3392)
- Hengli Lai
- Yuan Liu (ORCID: https://orcid.org/0000-0001-7514-8876)
- Ganwei Xiong
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiujiang First People's Hospital (CN)
- Jiangxi Provincial People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3389/fcvm.2024.1495377
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00